Vitamin D3 breakthrough halves risk of second heart attack
12 days ago
- #vitamin D
- #medical research
- #heart health
- Personalized vitamin D3 treatment reduces second heart attack risk by 50%.
- Intermountain Health's 'target-to-treat' approach adjusts doses based on blood levels.
- Study involved 630 heart attack survivors monitored from 2017 to 2025.
- Optimal vitamin D levels targeted above 40 ng/mL with frequent monitoring.
- Higher initial doses (5,000 IU) often needed compared to standard recommendations.
- No adverse effects observed with higher vitamin D3 supplementation.
- Global significance as many people have low vitamin D levels.
- Future plans include larger trials to confirm findings and explore broader impacts.